Insider Transactions in Q1 2024 at Willis Towers Watson PLC (WTW)
Insider Transaction List (Q1 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 01
2024
|
Andrew Jay Krasner Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
1,100
-20.87%
|
$299,200
$272.13 P/Share
|
Feb 28
2024
|
Carl Aaron Hess Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
159
-0.21%
|
$43,725
$275.06 P/Share
|
Feb 27
2024
|
Imran Ahmed Qureshi Head of North America |
BUY
Grant, award, or other acquisition
|
Direct |
768
+15.12%
|
-
|
Feb 27
2024
|
Carl Aaron Hess Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,213
+5.32%
|
-
|
Feb 27
2024
|
Alexis Faber Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,002
+14.72%
|
-
|
Feb 27
2024
|
Kristy D Banas Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,759
+16.77%
|
-
|
Feb 27
2024
|
Joseph Stephen Kurpis PAO and Controller |
BUY
Grant, award, or other acquisition
|
Direct |
251
+20.59%
|
-
|
Feb 27
2024
|
Pamela Thomson Hall Head of International |
BUY
Grant, award, or other acquisition
|
Direct |
668
+14.33%
|
-
|
Feb 27
2024
|
Adam Garrard Head of Risk & Broking |
BUY
Grant, award, or other acquisition
|
Direct |
3,964
+20.65%
|
-
|
Feb 27
2024
|
Matthew Furman General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
3,241
+8.69%
|
-
|
Feb 27
2024
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
BUY
Grant, award, or other acquisition
|
Direct |
4,213
+5.47%
|
-
|
Feb 27
2024
|
Anne Pullum Head of Europe |
BUY
Grant, award, or other acquisition
|
Direct |
3,479
+19.06%
|
-
|
Feb 20
2024
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
SELL
Open market or private sale
|
Direct |
5,000
-6.8%
|
$1,380,000
$276.03 P/Share
|
Feb 08
2024
|
Adam Garrard Head of Risk & Broking |
SELL
Open market or private sale
|
Direct |
5,400
-32.41%
|
$1,458,000
$270.41 P/Share
|
Jan 16
2024
|
Matthew Furman General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
3
+0.01%
|
-
|
Jan 16
2024
|
Joseph Stephen Kurpis PAO and Controller |
BUY
Grant, award, or other acquisition
|
Direct |
0
|
-
|
Jan 16
2024
|
Anne Pullum Head of Europe |
BUY
Grant, award, or other acquisition
|
Direct |
4
+0.04%
|
-
|
Jan 16
2024
|
Adam Garrard Head of Risk & Broking |
BUY
Grant, award, or other acquisition
|
Direct |
7
+0.04%
|
-
|
Jan 16
2024
|
Pamela Thomson Hall Head of International |
BUY
Grant, award, or other acquisition
|
Direct |
1
+0.03%
|
-
|
Jan 16
2024
|
Andrew Jay Krasner Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5
+0.07%
|
-
|
Jan 16
2024
|
Kristy D Banas Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2
+0.06%
|
-
|
Jan 16
2024
|
Alexis Faber Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2
+0.04%
|
-
|
Jan 16
2024
|
Imran Ahmed Qureshi Head of North America |
BUY
Grant, award, or other acquisition
|
Direct |
3
+0.08%
|
-
|
Jan 16
2024
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
BUY
Grant, award, or other acquisition
|
Direct |
7
+0.01%
|
-
|
Jan 16
2024
|
Carl Aaron Hess Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
31
+0.04%
|
-
|